Chemical,Chemical ID,Gene,Gene ID,Phenotype,Phenotype ID,Disease,Disease ID,Evidence Strength Score
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Hypertension,D006973,1000
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Inflammation,D007249,720
Prednisolone,D011239,NR3C1,2908,apoptotic process,GO:0006915,Hypertension,D006973,700
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,"Arthritis, Rheumatoid",D001172,660
Prednisolone,D011239,IFNG,3458,apoptotic process,GO:0006915,Proteinuria,D011507,640
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,"Colitis, Ulcerative",D003093,480
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Inflammation,D007249,448
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,"Arthritis, Rheumatoid",D001172,385
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Hypertension,D006973,350
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Chemical and Drug Induced Liver Injury,D056486,343
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Fever,D005334,300
Prednisolone,D011239,ALB,213,bilirubin transport,GO:0015723,Proteinuria,D011507,288
Prednisolone,D011239,IFNG,3458,apoptotic process,GO:0006915,Chemical and Drug Induced Liver Injury,D056486,280
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Chemical and Drug Induced Liver Injury,D056486,280
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Asthma,D001249,252
Prednisolone,D011239,IL6,3569,cell redox homeostasis,GO:0045454,Hypertension,D006973,250
Prednisolone,D011239,IL6,3569,positive regulation of apoptotic DNA fragmentation,GO:1902512,Hypertension,D006973,250
Prednisolone,D011239,IL6,3569,positive regulation of nitric oxide biosynthetic process,GO:0045429,Hypertension,D006973,250
Prednisolone,D011239,IFNG,3458,apoptotic process,GO:0006915,Inflammation,D007249,240
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Myocardial Infarction,D009203,240
Prednisolone,D011239,IFNG,3458,apoptotic process,GO:0006915,"Arthritis, Rheumatoid",D001172,220
Prednisolone,D011239,IL6,3569,cell redox homeostasis,GO:0045454,Inflammation,D007249,220
Prednisolone,D011239,IL6,3569,positive regulation of apoptotic DNA fragmentation,GO:1902512,Inflammation,D007249,220
Prednisolone,D011239,IL6,3569,positive regulation of nitric oxide biosynthetic process,GO:0045429,Inflammation,D007249,220
Prednisolone,D011239,IL1B,3553,positive regulation of nitric oxide biosynthetic process,GO:0045429,Hypertension,D006973,200
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Glomerulonephritis,D005921,160
Prednisolone,D011239,KMT2A,4297,apoptotic process,GO:0006915,Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054198,150
Prednisolone,D011239,IL1B,3553,positive regulation of nitric oxide biosynthetic process,GO:0045429,Inflammation,D007249,144
Prednisolone,D011239,TGFB1,7040,cell population proliferation,GO:0008283,Nephrotic Syndrome,D009404,144
Prednisolone,D011239,NR3C1,2908,bone mineralization,GO:0030282,Hypertension,D006973,140
Prednisolone,D011239,NR3C1,2908,apoptotic process,GO:0006915,Ocular Hypertension,D009798,140
Prednisolone,D011239,IL1B,3553,positive regulation of nitric oxide biosynthetic process,GO:0045429,"Arthritis, Rheumatoid",D001172,132
Prednisolone,D011239,IFNG,3458,positive regulation of nitric oxide biosynthetic process,GO:0045429,Proteinuria,D011507,128
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,"Colitis, Ulcerative",D003093,126
Prednisolone,D011239,IFNG,3458,apoptotic process,GO:0006915,Fever,D005334,120
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Asthma,D001249,120
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Hyperalgesia,D006930,120
Prednisolone,D011239,IL6,3569,cell redox homeostasis,GO:0045454,Multiple Myeloma,D009101,120
Prednisolone,D011239,IL6,3569,positive regulation of apoptotic DNA fragmentation,GO:1902512,Multiple Myeloma,D009101,120
Prednisolone,D011239,IL6,3569,positive regulation of nitric oxide biosynthetic process,GO:0045429,Multiple Myeloma,D009101,120
Prednisolone,D011239,IL6,3569,cell redox homeostasis,GO:0045454,"Arthritis, Rheumatoid",D001172,110
Prednisolone,D011239,IL6,3569,positive regulation of apoptotic DNA fragmentation,GO:1902512,"Arthritis, Rheumatoid",D001172,110
Prednisolone,D011239,IL6,3569,positive regulation of nitric oxide biosynthetic process,GO:0045429,"Arthritis, Rheumatoid",D001172,110
Prednisolone,D011239,LCN2,3934,apoptotic process,GO:0006915,Acute Kidney Injury,D058186,100
Prednisolone,D011239,IFNG,3458,apoptotic process,GO:0006915,Graft vs Host Disease,D006086,100
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Muscular Diseases,D009135,100
Prednisolone,D011239,ALB,213,bilirubin transport,GO:0015723,"Nephritis, Interstitial",D009395,96
Prednisolone,D011239,IL1B,3553,positive regulation of nitric oxide biosynthetic process,GO:0045429,"Colitis, Ulcerative",D003093,96
Prednisolone,D011239,VEGFA,7422,apoptotic process,GO:0006915,Asthma,D001249,90
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Acute Kidney Injury,D058186,84
Prednisolone,D011239,IFNG,3458,apoptotic process,GO:0006915,Glomerulonephritis,D005921,80
Prednisolone,D011239,IFNG,3458,apoptotic process,GO:0006915,Renal Insufficiency,D051437,80
Prednisolone,D011239,IL12B,3593,cell population proliferation,GO:0008283,"Lupus Erythematosus, Systemic",D008180,80
Prednisolone,D011239,TGFB1,7040,cell population proliferation,GO:0008283,Hypertension,D006973,80
Prednisolone,D011239,VEGFA,7422,apoptotic process,GO:0006915,Proteinuria,D011507,80
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Hyperalgesia,D006930,77
Prednisolone,D011239,IL12B,3593,cell population proliferation,GO:0008283,"Colitis, Ulcerative",D003093,72
Prednisolone,D011239,NR3C1,2908,apoptotic process,GO:0006915,Drug-Related Side Effects and Adverse Reactions,D064420,70
Prednisolone,D011239,IL6,3569,positive regulation of nitric oxide biosynthetic process,GO:0045429,Chemical and Drug Induced Liver Injury,D056486,70
Prednisolone,D011239,NR3C1,2908,apoptotic process,GO:0006915,Depressive Disorder,D003866,70
Prednisolone,D011239,LCN2,3934,apoptotic process,GO:0006915,Chemical and Drug Induced Liver Injury,D056486,70
Prednisolone,D011239,IL6,3569,positive regulation of apoptotic DNA fragmentation,GO:1902512,Chemical and Drug Induced Liver Injury,D056486,70
Prednisolone,D011239,IL6,3569,cell redox homeostasis,GO:0045454,Chemical and Drug Induced Liver Injury,D056486,70
Prednisolone,D011239,IL17A,3605,apoptotic process,GO:0006915,Chemical and Drug Induced Liver Injury,D056486,70
Prednisolone,D011239,AHR,196,apoptotic process,GO:0006915,Chemical and Drug Induced Liver Injury,D056486,70
Prednisolone,D011239,ALB,213,bilirubin transport,GO:0015723,Glomerulonephritis,D005921,64
Prednisolone,D011239,TGFB1,7040,cell population proliferation,GO:0008283,Proteinuria,D011507,64
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Fever,D005334,63
Prednisolone,D011239,IL1B,3553,positive regulation of nitric oxide biosynthetic process,GO:0045429,Fever,D005334,60
Prednisolone,D011239,TF,7018,apoptotic process,GO:0006915,Nephrotic Syndrome,D009404,60
Prednisolone,D011239,STAT4,6775,cell population proliferation,GO:0008283,"Lupus Erythematosus, Systemic",D008180,60
Prednisolone,D011239,MMP9,4318,apoptotic process,GO:0006915,Asthma,D001249,60
Prednisolone,D011239,THBS1,7057,apoptotic process,GO:0006915,"Nephritis, Interstitial",D009395,60
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Lethargy,D053609,60
Prednisolone,D011239,IFNG,3458,apoptotic process,GO:0006915,"Hepatitis, Autoimmune",D019693,60
Prednisolone,D011239,CCL2,6347,leukocyte migration involved in inflammatory response,GO:0002523,Hypertension,D006973,60
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Breast Neoplasms,D001943,60
Prednisolone,D011239,IFNG,3458,positive regulation of nitric oxide biosynthetic process,GO:0045429,Chemical and Drug Induced Liver Injury,D056486,56
Prednisolone,D011239,IL1B,3553,positive regulation of nitric oxide biosynthetic process,GO:0045429,Chemical and Drug Induced Liver Injury,D056486,56
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Glomerulonephritis,D005921,56
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Myocardial Infarction,D009203,56
Prednisolone,D011239,LCN2,3934,apoptotic process,GO:0006915,"Arthritis, Rheumatoid",D001172,55
Prednisolone,D011239,VEGFA,7422,apoptotic process,GO:0006915,"Arthritis, Rheumatoid",D001172,55
Prednisolone,D011239,TLR2,7097,apoptotic process,GO:0006915,"Arthritis, Rheumatoid",D001172,55
Prednisolone,D011239,MARCKS,4082,apoptotic process,GO:0006915,"Arthritis, Rheumatoid",D001172,55
Prednisolone,D011239,AHR,196,apoptotic process,GO:0006915,"Arthritis, Rheumatoid",D001172,55
Prednisolone,D011239,CXCR4,7852,apoptotic process,GO:0006915,"Arthritis, Rheumatoid",D001172,55
Prednisolone,D011239,CCN1,3491,apoptotic process,GO:0006915,"Arthritis, Rheumatoid",D001172,55
Prednisolone,D011239,BCL2A1,597,apoptotic process,GO:0006915,"Arthritis, Rheumatoid",D001172,55
Prednisolone,D011239,ADORA2A,135,apoptotic process,GO:0006915,"Arthritis, Rheumatoid",D001172,55
Prednisolone,D011239,JUN,3725,apoptotic process,GO:0006915,Hypertension,D006973,50
Prednisolone,D011239,MMP9,4318,apoptotic process,GO:0006915,Hypertension,D006973,50
Prednisolone,D011239,IL6,3569,positive regulation of nitric oxide biosynthetic process,GO:0045429,"Lupus Erythematosus, Systemic",D008180,50
Prednisolone,D011239,IL6,3569,cell redox homeostasis,GO:0045454,"Lupus Erythematosus, Systemic",D008180,50
Prednisolone,D011239,AHR,196,apoptotic process,GO:0006915,Hypertension,D006973,50
Prednisolone,D011239,IL6,3569,positive regulation of apoptotic DNA fragmentation,GO:1902512,"Lupus Erythematosus, Systemic",D008180,50
Prednisolone,D011239,ALB,213,bilirubin transport,GO:0015723,Nephrotic Syndrome,D009404,48
Prednisolone,D011239,IFNG,3458,positive regulation of nitric oxide biosynthetic process,GO:0045429,Inflammation,D007249,48
Prednisolone,D011239,IL1B,3553,positive regulation of nitric oxide biosynthetic process,GO:0045429,Myocardial Infarction,D009203,48
Prednisolone,D011239,TGFB1,7040,cell population proliferation,GO:0008283,Asthma,D001249,48
Prednisolone,D011239,ADORA2A,135,apoptotic process,GO:0006915,Substance Withdrawal Syndrome,D013375,45
Prednisolone,D011239,IL6,3569,cell redox homeostasis,GO:0045454,Fever,D005334,45
Prednisolone,D011239,IL6,3569,positive regulation of apoptotic DNA fragmentation,GO:1902512,Fever,D005334,45
Prednisolone,D011239,IL6,3569,positive regulation of nitric oxide biosynthetic process,GO:0045429,Fever,D005334,45
Prednisolone,D011239,IL10,3586,leukocyte chemotaxis,GO:0030595,"Arthritis, Rheumatoid",D001172,44
Prednisolone,D011239,IFNG,3458,positive regulation of nitric oxide biosynthetic process,GO:0045429,"Arthritis, Rheumatoid",D001172,44
Prednisolone,D011239,STAT4,6775,cell population proliferation,GO:0008283,"Arthritis, Rheumatoid",D001172,44
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Pneumonia,D011014,42
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Sepsis,D018805,42
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Edema,D004487,42
Prednisolone,D011239,IL6,3569,positive regulation of nitric oxide biosynthetic process,GO:0045429,Myocardial Infarction,D009203,40
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Pneumonia,D011014,40
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Psoriasis,D011565,40
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Pulmonary Fibrosis,D011658,40
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Sepsis,D018805,40
Prednisolone,D011239,IL6,3569,cell redox homeostasis,GO:0045454,Myocardial Infarction,D009203,40
Prednisolone,D011239,IL6,3569,positive regulation of apoptotic DNA fragmentation,GO:1902512,Myocardial Infarction,D009203,40
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Multiple Sclerosis,D009103,40
Prednisolone,D011239,LCN2,3934,apoptotic process,GO:0006915,Kidney Diseases,D007674,40
Prednisolone,D011239,MMP9,4318,apoptotic process,GO:0006915,Inflammation,D007249,40
Prednisolone,D011239,MMP9,4318,apoptotic process,GO:0006915,Myocardial Infarction,D009203,40
Prednisolone,D011239,PTGS2,5743,bone mineralization,GO:0030282,Hypertension,D006973,40
Prednisolone,D011239,PTGS2,5743,positive regulation of nitric oxide biosynthetic process,GO:0045429,Hypertension,D006973,40
Prednisolone,D011239,VEGFA,7422,apoptotic process,GO:0006915,Acute Kidney Injury,D058186,40
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Neutropenia,D009503,40
Prednisolone,D011239,IFNG,3458,apoptotic process,GO:0006915,Vomiting,D014839,40
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Hemolytic-Uremic Syndrome,D006463,40
Prednisolone,D011239,IFNG,3458,apoptotic process,GO:0006915,Pneumonia,D011014,40
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Dermatomyositis,D003882,40
Prednisolone,D011239,AHR,196,apoptotic process,GO:0006915,Inflammation,D007249,40
Prednisolone,D011239,IFNG,3458,apoptotic process,GO:0006915,Autoimmune Diseases,D001327,40
Prednisolone,D011239,IFNG,3458,apoptotic process,GO:0006915,Drug-Related Side Effects and Adverse Reactions,D064420,40
Prednisolone,D011239,IFNG,3458,apoptotic process,GO:0006915,Lupus Nephritis,D008181,40
Prednisolone,D011239,IFNG,3458,apoptotic process,GO:0006915,"Dermatitis, Atopic",D003876,40
Prednisolone,D011239,IFNG,3458,apoptotic process,GO:0006915,Sepsis,D018805,40
Prednisolone,D011239,IFNG,3458,apoptotic process,GO:0006915,Stevens-Johnson Syndrome,D013262,40
Prednisolone,D011239,AHR,196,apoptotic process,GO:0006915,Hepatomegaly,D006529,40
Prednisolone,D011239,IGF1,3479,cell population proliferation,GO:0008283,Hypertension,D006973,40
Prednisolone,D011239,IL10,3586,leukocyte chemotaxis,GO:0030595,"Lupus Erythematosus, Systemic",D008180,40
Prednisolone,D011239,IL1B,3553,apoptotic process,GO:0006915,Anorexia,D000855,40
Prednisolone,D011239,CCL2,6347,leukocyte migration involved in inflammatory response,GO:0002523,Inflammation,D007249,36
Prednisolone,D011239,CCL2,6347,leukocyte migration involved in inflammatory response,GO:0002523,"Nephritis, Interstitial",D009395,36
Prednisolone,D011239,VEGFA,7422,cell population proliferation,GO:0008283,Asthma,D001249,36
Prednisolone,D011239,TF,7018,apoptotic process,GO:0006915,Chemical and Drug Induced Liver Injury,D056486,35
Prednisolone,D011239,VEGFA,7422,apoptotic process,GO:0006915,Chemical and Drug Induced Liver Injury,D056486,35
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Pulmonary Fibrosis,D011658,35
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Muscular Atrophy,D009133,35
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,"Carcinoma, Transitional Cell",D002295,35
Prednisolone,D011239,THBS1,7057,apoptotic process,GO:0006915,Chemical and Drug Induced Liver Injury,D056486,35
Prednisolone,D011239,NR3C1,2908,apoptotic process,GO:0006915,Psychotic Disorders,D011618,35
Prednisolone,D011239,NR3C1,2908,apoptotic process,GO:0006915,Prostatic Neoplasms,D011471,35
Prednisolone,D011239,NR3C1,2908,apoptotic process,GO:0006915,Hypokalemia,D007008,35
Prednisolone,D011239,NR3C1,2908,apoptotic process,GO:0006915,Bipolar Disorder,D001714,35
Prednisolone,D011239,NFE2L2,4780,cell redox homeostasis,GO:0045454,Chemical and Drug Induced Liver Injury,D056486,35
Prednisolone,D011239,MMP9,4318,apoptotic process,GO:0006915,Chemical and Drug Induced Liver Injury,D056486,35
Prednisolone,D011239,SOD2,6648,hydrogen peroxide biosynthetic process,GO:0050665,"Arthritis, Rheumatoid",D001172,33
Prednisolone,D011239,SOD2,6648,locomotory behavior,GO:0007626,"Arthritis, Rheumatoid",D001172,33
Prednisolone,D011239,SOD2,6648,positive regulation of nitric oxide biosynthetic process,GO:0045429,"Arthritis, Rheumatoid",D001172,33
Prednisolone,D011239,SOD2,6648,superoxide dismutase activity,GO:0004784,"Arthritis, Rheumatoid",D001172,33
Prednisolone,D011239,PTGS2,5743,positive regulation of nitric oxide biosynthetic process,GO:0045429,Urinary Bladder Neoplasms,D001749,32
Prednisolone,D011239,VEGFA,7422,cell population proliferation,GO:0008283,Proteinuria,D011507,32
Prednisolone,D011239,TGFB1,7040,cell population proliferation,GO:0008283,Pulmonary Fibrosis,D011658,32
Prednisolone,D011239,TGFB1,7040,cell population proliferation,GO:0008283,Inflammation,D007249,32
Prednisolone,D011239,IL1B,3553,positive regulation of nitric oxide biosynthetic process,GO:0045429,Glomerulonephritis,D005921,32
Prednisolone,D011239,PTGS2,5743,bone mineralization,GO:0030282,Urinary Bladder Neoplasms,D001749,32
Prednisolone,D011239,ALB,213,bilirubin transport,GO:0015723,Kidney Diseases,D007674,32
Prednisolone,D011239,ALB,213,bilirubin transport,GO:0015723,Acute Kidney Injury,D058186,32
Prednisolone,D011239,IL6,3569,positive regulation of nitric oxide biosynthetic process,GO:0045429,Edema,D004487,30
Prednisolone,D011239,SOD2,6648,positive regulation of nitric oxide biosynthetic process,GO:0045429,Hypertension,D006973,30
Prednisolone,D011239,SOD2,6648,locomotory behavior,GO:0007626,Hypertension,D006973,30
Prednisolone,D011239,SOD2,6648,hydrogen peroxide biosynthetic process,GO:0050665,Hypertension,D006973,30
Prednisolone,D011239,RIPK2,8767,apoptotic process,GO:0006915,"Colitis, Ulcerative",D003093,30
Prednisolone,D011239,NOS2,4843,cell redox homeostasis,GO:0045454,Hypertension,D006973,30
Prednisolone,D011239,MMP9,4318,apoptotic process,GO:0006915,"Colitis, Ulcerative",D003093,30
Prednisolone,D011239,SOD2,6648,superoxide dismutase activity,GO:0004784,Hypertension,D006973,30
Prednisolone,D011239,IL6,3569,positive regulation of nitric oxide biosynthetic process,GO:0045429,Asthma,D001249,30
Prednisolone,D011239,CASP3,836,apoptotic process,GO:0006915,Edema,D004487,30
Prednisolone,D011239,AHR,196,apoptotic process,GO:0006915,Edema,D004487,30
Prednisolone,D011239,CASP3,836,apoptotic process,GO:0006915,"Colitis, Ulcerative",D003093,30
Prednisolone,D011239,IL6,3569,positive regulation of apoptotic DNA fragmentation,GO:1902512,Edema,D004487,30
Prednisolone,D011239,IL6,3569,cell redox homeostasis,GO:0045454,Asthma,D001249,30
Prednisolone,D011239,IL6,3569,positive regulation of apoptotic DNA fragmentation,GO:1902512,Asthma,D001249,30
Prednisolone,D011239,IL6,3569,cell redox homeostasis,GO:0045454,Edema,D004487,30
Prednisolone,D011239,NR3C1,2908,bone mineralization,GO:0030282,Ocular Hypertension,D009798,28
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Psoriasis,D011565,28
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Obesity,D009765,28
Prednisolone,D011239,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Urinary Bladder Neoplasms,D001749,28
Prednisolone,D011239,IL12B,3593,cell population proliferation,GO:0008283,Chemical and Drug Induced Liver Injury,D056486,28
Prednisolone,D011239,ALB,213,bilirubin transport,GO:0015723,Chemical and Drug Induced Liver Injury,D056486,28
Prednisolone,D011239,IGF1,3479,cell population proliferation,GO:0008283,Chemical and Drug Induced Liver Injury,D056486,28
Prednisolone,D011239,KMT2A,4297,apoptotic process,GO:0006915,"Carcinoma, Transitional Cell",D002295,25
Prednisolone,D011239,IL6,3569,positive regulation of nitric oxide biosynthetic process,GO:0045429,Prostatic Neoplasms,D011471,25
Prednisolone,D011239,IL6,3569,positive regulation of apoptotic DNA fragmentation,GO:1902512,Prostatic Neoplasms,D011471,25
Prednisolone,D011239,IL6,3569,cell redox homeostasis,GO:0045454,Prostatic Neoplasms,D011471,25
Prednisolone,D011239,IL17A,3605,apoptotic process,GO:0006915,Graft vs Host Disease,D006086,25
Prednisolone,D011239,IFNG,3458,positive regulation of nitric oxide biosynthetic process,GO:0045429,Fever,D005334,24
Prednisolone,D011239,IL10,3586,leukocyte chemotaxis,GO:0030595,"Colitis, Ulcerative",D003093,24
Prednisolone,D011239,IL12B,3593,cell population proliferation,GO:0008283,Psoriasis,D011565,24
Prednisolone,D011239,IL1B,3553,positive regulation of nitric oxide biosynthetic process,GO:0045429,Asthma,D001249,24
Prednisolone,D011239,IL1B,3553,positive regulation of nitric oxide biosynthetic process,GO:0045429,Hyperalgesia,D006930,24
Resveratrol,D000077185,IL1B,3553,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,169632
Quercetin,D011794,IL1B,3553,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,147312
Resveratrol,D000077185,TNF,7124,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,141840
Resveratrol,D000077185,IL1B,3553,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,133920
Resveratrol,D000077185,PTGS2,5743,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,117720
Fluorouracil,D005472,IL1B,3553,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,108000
Cisplatin,D002945,IL1B,3553,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,104490
Lipopolysaccharides,D008070,IL1B,3553,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,100572
Resveratrol,D000077185,TNF,7124,positive regulation of cell population proliferation,GO:0008284,Colonic Neoplasms,D003110,99288
Lipopolysaccharides,D008070,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Colonic Neoplasms,D003110,98488
Resveratrol,D000077185,IL1B,3553,positive regulation of cell population proliferation,GO:0008284,Colonic Neoplasms,D003110,93744
Lipopolysaccharides,D008070,IL1B,3553,positive regulation of nitric oxide biosynthetic process,GO:0045429,Colonic Neoplasms,D003110,90168
Resveratrol,D000077185,PTGS2,5743,positive regulation of cell population proliferation,GO:0008284,Colonic Neoplasms,D003110,82404
Resveratrol,D000077185,TNF,7124,negative regulation of cell population proliferation,GO:0008285,Colonic Neoplasms,D003110,66192
Resveratrol,D000077185,IL1B,3553,negative regulation of cell population proliferation,GO:0008285,Colonic Neoplasms,D003110,62496
Resveratrol,D000077185,TNF,7124,negative regulation of mitotic cell cycle,GO:0045930,Colonic Neoplasms,D003110,61464
Resveratrol,D000077185,NOS2,4843,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,61200
Quercetin,D011794,TNF,7124,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,59148
Resveratrol,D000077185,PTGS2,5743,negative regulation of cell population proliferation,GO:0008285,Colonic Neoplasms,D003110,54936
Lipopolysaccharides,D008070,TNF,7124,positive regulation of NF-kappaB transcription factor activity,GO:0051092,Colonic Neoplasms,D003110,54926
Acetylcysteine,D000111,IL1B,3553,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,54093
Quercetin,D011794,IL1B,3553,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,51894
Lipopolysaccharides,D008070,TNF,7124,positive regulation of inflammatory response,GO:0050729,Colonic Neoplasms,D003110,51138
Quercetin,D011794,TNF,7124,negative regulation of mitotic cell cycle,GO:0045930,Colonic Neoplasms,D003110,47700
Lipopolysaccharides,D008070,TNF,7124,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,47350
Lipopolysaccharides,D008070,IL1B,3553,positive regulation of inflammatory response,GO:0050729,Colonic Neoplasms,D003110,46818
Lipopolysaccharides,D008070,PTGS2,5743,positive regulation of nitric oxide biosynthetic process,GO:0045429,Colonic Neoplasms,D003110,46644
Fluorouracil,D005472,VEGFA,7422,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,44000
Quercetin,D011794,TNF,7124,positive regulation of cell population proliferation,GO:0008284,Colonic Neoplasms,D003110,43884
Quercetin,D011794,PTGS2,5743,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,43524
Lipopolysaccharides,D008070,IL1B,3553,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,43350
Lipopolysaccharides,D008070,NOS2,4843,nitric oxide biosynthetic process,GO:0006809,Colonic Neoplasms,D003110,41448
Cisplatin,D002945,TNF,7124,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,39480
Quercetin,D011794,IL1B,3553,positive regulation of cell population proliferation,GO:0008284,Colonic Neoplasms,D003110,38502
Quercetin,D011794,NOS2,4843,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,38502
Lipopolysaccharides,D008070,IL1B,3553,positive regulation of p38MAPK cascade,GO:1900745,Colonic Neoplasms,D003110,38148
Indomethacin,D007213,PTGS2,5743,regulation of blood pressure,GO:0008217,Colonic Neoplasms,D003110,36792
Quercetin,D011794,JUN,3725,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,36432
Lipopolysaccharides,D008070,TNF,7124,inflammatory response,GO:0006954,Colonic Neoplasms,D003110,35986
Resveratrol,D000077185,PTGS2,5743,response to oxidative stress,GO:0006979,Colonic Neoplasms,D003110,35316
Resveratrol,D000077185,JUN,3725,cell population proliferation,GO:0008283,Colonic Neoplasms,D003110,35280
Quercetin,D011794,JUN,3725,cell population proliferation,GO:0008283,Colonic Neoplasms,D003110,35190
Cisplatin,D002945,JUN,3725,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,34020
Lipopolysaccharides,D008070,IL1B,3553,inflammatory response,GO:0006954,Colonic Neoplasms,D003110,32946
Quercetin,D011794,PTGS2,5743,positive regulation of cell population proliferation,GO:0008284,Colonic Neoplasms,D003110,32292
Resveratrol,D000077185,VEGFA,7422,cell population proliferation,GO:0008283,Colonic Neoplasms,D003110,30576
Cisplatin,D002945,IL1B,3553,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,30315
Lipopolysaccharides,D008070,TNF,7124,positive regulation of NIK/NF-kappaB signaling,GO:1901224,Colonic Neoplasms,D003110,30304
Fluorouracil,D005472,VEGFA,7422,cell population proliferation,GO:0008283,Colonic Neoplasms,D003110,29920
Dietary Fats,D004041,TNF,7124,inflammatory response,GO:0006954,Colonic Neoplasms,D003110,29800
Resveratrol,D000077185,MMP9,4318,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,29184
Dexamethasone,D003907,IL1B,3553,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,28875
Lipopolysaccharides,D008070,IL1B,3553,positive regulation of NIK/NF-kappaB signaling,GO:1901224,Colonic Neoplasms,D003110,27744
Resveratrol,D000077185,JUN,3725,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,27360
Quercetin,D011794,NOS2,4843,nitric oxide biosynthetic process,GO:0006809,Colonic Neoplasms,D003110,27324
Dietary Fats,D004041,IL1B,3553,inflammatory response,GO:0006954,Colonic Neoplasms,D003110,27300
Resveratrol,D000077185,IL1B,3553,positive regulation of p38MAPK cascade,GO:1900745,Colonic Neoplasms,D003110,24552
Dextran Sulfate,D016264,IL1B,3553,inflammatory response,GO:0006954,Colonic Neoplasms,D003110,24528
Cisplatin,D002945,TNF,7124,negative regulation of cell population proliferation,GO:0008285,Colonic Neoplasms,D003110,24360
Fluorouracil,D005472,IFNG,3458,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,24000
Fluorouracil,D005472,JUN,3725,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,24000
Quercetin,D011794,MMP9,4318,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,23760
Resveratrol,D000077185,VEGFA,7422,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,23712
Resveratrol,D000077185,TNF,7124,inflammatory response,GO:0006954,Colonic Neoplasms,D003110,23640
Resveratrol,D000077185,TNF,7124,positive regulation of NF-kappaB transcription factor activity,GO:0051092,Colonic Neoplasms,D003110,23640
Lipopolysaccharides,D008070,NOS2,4843,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,23550
Resveratrol,D000077185,MMP9,4318,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,23040
Quercetin,D011794,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Colonic Neoplasms,D003110,22896
Lipopolysaccharides,D008070,TNF,7124,positive regulation of cytokine production involved in inflammatory response,GO:1900017,Colonic Neoplasms,D003110,22728
Lipopolysaccharides,D008070,PTGS2,5743,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,22425
Dietary Fats,D004041,TNF,7124,glucose metabolic process,GO:0006006,Colonic Neoplasms,D003110,22350
Resveratrol,D000077185,IL1B,3553,inflammatory response,GO:0006954,Colonic Neoplasms,D003110,22320
Fluorouracil,D005472,PTGS2,5743,negative regulation of cell population proliferation,GO:0008285,Colonic Neoplasms,D003110,21840
Quercetin,D011794,IL1B,3553,positive regulation of p38MAPK cascade,GO:1900745,Colonic Neoplasms,D003110,21762
Resveratrol,D000077185,JUN,3725,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,21600
Resveratrol,D000077185,TNF,7124,positive regulation of NIK/NF-kappaB signaling,GO:1901224,Colonic Neoplasms,D003110,21276
Resveratrol,D000077185,TNF,7124,positive regulation of nitric oxide biosynthetic process,GO:0045429,Colonic Neoplasms,D003110,21276
Lipopolysaccharides,D008070,TNF,7124,negative regulation of cell population proliferation,GO:0008285,Colonic Neoplasms,D003110,20834
Lipopolysaccharides,D008070,TNF,7124,positive regulation of cell population proliferation,GO:0008284,Colonic Neoplasms,D003110,20834
Resveratrol,D000077185,IL1B,3553,positive regulation of nitric oxide biosynthetic process,GO:0045429,Colonic Neoplasms,D003110,20088
Quercetin,D011794,IL1B,3553,positive regulation of nitric oxide biosynthetic process,GO:0045429,Colonic Neoplasms,D003110,20088
Resveratrol,D000077185,IL1B,3553,positive regulation of NIK/NF-kappaB signaling,GO:1901224,Colonic Neoplasms,D003110,20088
Lipopolysaccharides,D008070,IL1B,3553,negative regulation of cell population proliferation,GO:0008285,Colonic Neoplasms,D003110,19074
Lipopolysaccharides,D008070,IL1B,3553,positive regulation of cell population proliferation,GO:0008284,Colonic Neoplasms,D003110,19074
Cisplatin,D002945,PTGS2,5743,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,19035
Lipopolysaccharides,D008070,TNF,7124,positive regulation of JNK cascade,GO:0046330,Colonic Neoplasms,D003110,18940
Resveratrol,D000077185,TNF,7124,negative regulation of interleukin-6 production,GO:0032715,Colonic Neoplasms,D003110,18912
Resveratrol,D000077185,TNF,7124,positive regulation of interleukin-1 beta production,GO:0032731,Colonic Neoplasms,D003110,18912
Cisplatin,D002945,IL1B,3553,negative regulation of cell population proliferation,GO:0008285,Colonic Neoplasms,D003110,18705
Dextran Sulfate,D016264,IL1B,3553,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,18396
Resveratrol,D000077185,IFNG,3458,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,18240
Quercetin,D011794,VEGFA,7422,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,18216
Curcumin,D003474,IL1B,3553,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,18000
Lipopolysaccharides,D008070,NOS2,4843,inflammatory response,GO:0006954,Colonic Neoplasms,D003110,17898
Acetylcysteine,D000111,JUN,3725,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,17784
Resveratrol,D000077185,PTGS2,5743,positive regulation of nitric oxide biosynthetic process,GO:0045429,Colonic Neoplasms,D003110,17658
Quercetin,D011794,VEGFA,7422,cell population proliferation,GO:0008283,Colonic Neoplasms,D003110,17595
Dextran Sulfate,D016264,TNF,7124,inflammatory response,GO:0006954,Colonic Neoplasms,D003110,17472
Lipopolysaccharides,D008070,IL1B,3553,positive regulation of JNK cascade,GO:0046330,Colonic Neoplasms,D003110,17340
Acetylcysteine,D000111,IL1B,3553,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,17082
Quercetin,D011794,PTGS2,5743,positive regulation of nitric oxide biosynthetic process,GO:0045429,Colonic Neoplasms,D003110,16848
Resveratrol,D000077185,TNF,7124,vasodilation,GO:0042311,Colonic Neoplasms,D003110,16548
Resveratrol,D000077185,TNF,7124,positive regulation of ERK1 and ERK2 cascade,GO:0070374,Colonic Neoplasms,D003110,16548
Resveratrol,D000077185,TNF,7124,positive regulation of protein kinase B signaling,GO:0051897,Colonic Neoplasms,D003110,16548
Fluorouracil,D005472,JUN,3725,cell population proliferation,GO:0008283,Colonic Neoplasms,D003110,16320
Resveratrol,D000077185,IL1B,3553,positive regulation of cell migration,GO:0030335,Colonic Neoplasms,D003110,15624
Resveratrol,D000077185,IL1B,3553,positive regulation of ERK1 and ERK2 cascade,GO:0070374,Colonic Neoplasms,D003110,15624
Resveratrol,D000077185,IL1B,3553,positive regulation of protein kinase B signaling,GO:0051897,Colonic Neoplasms,D003110,15624
Quercetin,D011794,TNF,7124,positive regulation of NIK/NF-kappaB signaling,GO:1901224,Colonic Neoplasms,D003110,15264
Lipopolysaccharides,D008070,TNF,7124,microglial cell activation,GO:0001774,Colonic Neoplasms,D003110,15152
Lipopolysaccharides,D008070,TNF,7124,positive regulation of ERK1 and ERK2 cascade,GO:0070374,Colonic Neoplasms,D003110,15152
Lipopolysaccharides,D008070,TNF,7124,positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043123,Colonic Neoplasms,D003110,15152
Resveratrol,D000077185,JUN,3725,positive regulation of cell population proliferation,GO:0008284,Colonic Neoplasms,D003110,15120
Fluorouracil,D005472,IL1B,3553,negative regulation of cell population proliferation,GO:0008285,Colonic Neoplasms,D003110,15120
Dietary Fats,D004041,IL1B,3553,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,15015
Acetylcysteine,D000111,TNF,7124,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,14976
Resveratrol,D000077185,IFNG,3458,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,14400
Cisplatin,D002945,TNF,7124,negative regulation of mitotic cell cycle,GO:0045930,Colonic Neoplasms,D003110,14280
Resveratrol,D000077185,TNF,7124,positive regulation of inflammatory response,GO:0050729,Colonic Neoplasms,D003110,14184
Resveratrol,D000077185,TNF,7124,positive regulation of interleukin-6 production,GO:0032755,Colonic Neoplasms,D003110,14184
Fluorouracil,D005472,PTGS2,5743,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,14040
Aspirin,D001241,IL1B,3553,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,14022
Lipopolysaccharides,D008070,IL1B,3553,positive regulation of ERK1 and ERK2 cascade,GO:0070374,Colonic Neoplasms,D003110,13872
Lipopolysaccharides,D008070,IL1B,3553,positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043123,Colonic Neoplasms,D003110,13872
Cisplatin,D002945,JUN,3725,cell population proliferation,GO:0008283,Colonic Neoplasms,D003110,13440
Quercetin,D011794,IL1B,3553,positive regulation of NIK/NF-kappaB signaling,GO:1901224,Colonic Neoplasms,D003110,13392
Resveratrol,D000077185,IL1B,3553,positive regulation of inflammatory response,GO:0050729,Colonic Neoplasms,D003110,13392
Resveratrol,D000077185,IL1B,3553,positive regulation of interleukin-6 production,GO:0032755,Colonic Neoplasms,D003110,13392
Quercetin,D011794,TNF,7124,positive regulation of NF-kappaB transcription factor activity,GO:0051092,Colonic Neoplasms,D003110,13356
Lipopolysaccharides,D008070,TNF,7124,positive regulation of interleukin-1 beta production,GO:0032731,Colonic Neoplasms,D003110,13258
Resveratrol,D000077185,VEGFA,7422,positive regulation of cell population proliferation,GO:0008284,Colonic Neoplasms,D003110,13104
Quercetin,D011794,JUN,3725,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,12834
Indomethacin,D007213,NOS2,4843,regulation of blood pressure,GO:0008217,Colonic Neoplasms,D003110,12096
Fluorouracil,D005472,MMP9,4318,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,12000
Dietary Fats,D004041,TNF,7124,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,11920
Quercetin,D011794,IFNG,3458,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,11880
Resveratrol,D000077185,SOD2,6648,superoxide dismutase activity,GO:0004784,Colonic Neoplasms,D003110,11880
Resveratrol,D000077185,TNF,7124,negative regulation of apoptotic process,GO:0043066,Colonic Neoplasms,D003110,11820
Resveratrol,D000077185,TNF,7124,positive regulation of JNK cascade,GO:0046330,Colonic Neoplasms,D003110,11820
Resveratrol,D000077185,TNF,7124,response to xenobiotic stimulus,GO:0009410,Colonic Neoplasms,D003110,11820
Cisplatin,D002945,PTGS2,5743,negative regulation of cell population proliferation,GO:0008285,Colonic Neoplasms,D003110,11745
Doxorubicin,D004317,IL1B,3553,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,11712
Lipopolysaccharides,D008070,TNF,7124,positive regulation of protein kinase B signaling,GO:0051897,Colonic Neoplasms,D003110,11364
Indomethacin,D007213,IL1B,3553,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,11286
Quercetin,D011794,PTGS2,5743,prostaglandin biosynthetic process,GO:0001516,Colonic Neoplasms,D003110,11232
Fluorouracil,D005472,TNF,7124,negative regulation of cell population proliferation,GO:0008285,Colonic Neoplasms,D003110,11200
Indomethacin,D007213,TNF,7124,vasodilation,GO:0042311,Colonic Neoplasms,D003110,11172
Resveratrol,D000077185,IL1B,3553,positive regulation of JNK cascade,GO:0046330,Colonic Neoplasms,D003110,11160
Resveratrol,D000077185,IL1B,3553,positive regulation of prostaglandin biosynthetic process,GO:0031394,Colonic Neoplasms,D003110,11160
Resveratrol,D000077185,IL1B,3553,response to xenobiotic stimulus,GO:0009410,Colonic Neoplasms,D003110,11160
Dietary Fats,D004041,IL1B,3553,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,10920
Fluorouracil,D005472,PTGS2,5743,positive regulation of cell population proliferation,GO:0008284,Colonic Neoplasms,D003110,10920
Melatonin,D008550,IL1B,3553,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,10626
Lipopolysaccharides,D008070,IL1B,3553,positive regulation of prostaglandin biosynthetic process,GO:0031394,Colonic Neoplasms,D003110,10404
Lipopolysaccharides,D008070,IL1B,3553,positive regulation of prostaglandin secretion,GO:0032308,Colonic Neoplasms,D003110,10404
Lipopolysaccharides,D008070,IL1B,3553,positive regulation of protein kinase B signaling,GO:0051897,Colonic Neoplasms,D003110,10404
Acetylcysteine,D000111,PTGS2,5743,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,10296
Resveratrol,D000077185,SOD2,6648,reactive oxygen species metabolic process,GO:0072593,Colonic Neoplasms,D003110,10230
Resveratrol,D000077185,NOS2,4843,inflammatory response,GO:0006954,Colonic Neoplasms,D003110,10200
Cisplatin,D002945,TNF,7124,positive regulation of cell population proliferation,GO:0008284,Colonic Neoplasms,D003110,10080
Resveratrol,D000077185,IFNG,3458,positive regulation of cell population proliferation,GO:0008284,Colonic Neoplasms,D003110,10080
Resveratrol,D000077185,JUN,3725,negative regulation of cell population proliferation,GO:0008285,Colonic Neoplasms,D003110,10080
Quercetin,D011794,IL1B,3553,positive regulation of cell migration,GO:0030335,Colonic Neoplasms,D003110,10044
Lipopolysaccharides,D008070,IFNG,3458,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,10034
Cisplatin,D002945,JUN,3725,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,9870
Cisplatin,D002945,NOS2,4843,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,9870
Lipopolysaccharides,D008070,PTGS2,5743,prostaglandin biosynthetic process,GO:0001516,Colonic Neoplasms,D003110,9867
Lipopolysaccharides,D008070,PTGS2,5743,positive regulation of cell population proliferation,GO:0008284,Colonic Neoplasms,D003110,9867
Lipopolysaccharides,D008070,PTGS2,5743,negative regulation of cell population proliferation,GO:0008285,Colonic Neoplasms,D003110,9867
Resveratrol,D000077185,PTGS2,5743,negative regulation of apoptotic process,GO:0043066,Colonic Neoplasms,D003110,9810
Resveratrol,D000077185,PTGS2,5743,positive regulation of prostaglandin biosynthetic process,GO:0031394,Colonic Neoplasms,D003110,9810
Resveratrol,D000077185,PTGS2,5743,response to xenobiotic stimulus,GO:0009410,Colonic Neoplasms,D003110,9810
Fluorouracil,D005472,IL1B,3553,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,9720
Quercetin,D011794,TNF,7124,negative regulation of cell population proliferation,GO:0008285,Colonic Neoplasms,D003110,9540
Quercetin,D011794,TNF,7124,positive regulation of inflammatory response,GO:0050729,Colonic Neoplasms,D003110,9540
Quercetin,D011794,JUN,3725,positive regulation of cell population proliferation,GO:0008284,Colonic Neoplasms,D003110,9522
Resveratrol,D000077185,TNF,7124,astrocyte activation,GO:0048143,Colonic Neoplasms,D003110,9456
Resveratrol,D000077185,TNF,7124,negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043124,Colonic Neoplasms,D003110,9456
Resveratrol,D000077185,SOD2,6648,negative regulation of cell population proliferation,GO:0008285,Colonic Neoplasms,D003110,9240
Dextran Sulfate,D016264,IL1B,3553,positive regulation of inflammatory response,GO:0050729,Colonic Neoplasms,D003110,9198
Lipopolysaccharides,D008070,IFNG,3458,positive regulation of nitric oxide biosynthetic process,GO:0045429,Colonic Neoplasms,D003110,8996
Dietary Fats,D004041,TNF,7124,positive regulation of inflammatory response,GO:0050729,Colonic Neoplasms,D003110,8940
Resveratrol,D000077185,IL1B,3553,astrocyte activation,GO:0048143,Colonic Neoplasms,D003110,8928
Resveratrol,D000077185,IL1B,3553,memory,GO:0007613,Colonic Neoplasms,D003110,8928
Resveratrol,D000077185,IL1B,3553,positive regulation of lipid catabolic process,GO:0050996,Colonic Neoplasms,D003110,8928
Cisplatin,D002945,MMP9,4318,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,8910
Curcumin,D003474,TNF,7124,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,8848
Curcumin,D003474,PTGS2,5743,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,8736
Resveratrol,D000077185,SOD2,6648,glutathione metabolic process,GO:0006749,Colonic Neoplasms,D003110,8580
Curcumin,D003474,IL1B,3553,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,8400
Quercetin,D011794,MMP9,4318,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,8370
Quercetin,D011794,IL1B,3553,positive regulation of inflammatory response,GO:0050729,Colonic Neoplasms,D003110,8370
Quercetin,D011794,IL1B,3553,negative regulation of cell population proliferation,GO:0008285,Colonic Neoplasms,D003110,8370
Doxorubicin,D004317,TNF,7124,positive regulation of apoptotic process,GO:0043065,Colonic Neoplasms,D003110,8268
Dietary Fats,D004041,IL1B,3553,positive regulation of inflammatory response,GO:0050729,Colonic Neoplasms,D003110,8190
Cisplatin,D002945,VEGFA,7422,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,8100
Resveratrol,D000077185,PTGS2,5743,memory,GO:0007613,Colonic Neoplasms,D003110,7848
Cisplatin,D002945,IL1B,3553,positive regulation of cell population proliferation,GO:0008284,Colonic Neoplasms,D003110,7740
Celecoxib,D000068579,IL1B,3553,apoptotic process,GO:0006915,Colonic Neoplasms,D003110,7680
Acetylcysteine,D000111,IL1B,3553,negative regulation of cell population proliferation,GO:0008285,Colonic Neoplasms,D003110,7665
